Compound ID | 143
Class: Lipopolysaccharide synthesis inhibitor (LpxC inhibitor)
Spectrum of activity: | Gram-negative |
Details of activity: | Gram negative effective |
Institute where first reported: | Achaogen, USA |
Year first mentioned: | 2012 |
Highest developmental phase: | Phase 1 |
Development status: | Discontinued |
Reason Dropped: | Toxicity |
Chemical structure(s): | |||||||||||
|
|